Grapeseed extract blocks colorectal tumor growth in human cells and animals
An article published in the October 18, 2006 issue of the journal Clinical Cancer Research reported the finding of researchers at the University of Colorado Health Sciences Center in Denver that grape seed extract inhibits the growth of human colorectal tumors in cell cultures as well as in mice.
“Many phytochemicals of diverse chemical nature, such as bioflavonoids, proanthocyanidins, and phytoestrogens, have shown promising chemopreventive and/or anticancer efficacy in various cell culture and animal models,” the authors write in their introduction. “A rich source of proanthocyanidins is grape seed extract (GSE), which was studied for its anticancer activity against colorectal cancer in the present investigation . . . GSE is widely marketed as a dietary supplement and is considered safe for human consumption.”
Rajesh Agarwal, PhD, who is a professor in the Department of Pharmaceutical Sciences, and his colleagues at UCHSC administered three concentrations of grape seed extract in DMSO or DMSO alone to two cultured human colorectal cancer cell lines. They found an inhibition of cell growth that increased with the concentration and time exposed to grape seed extract, and an increase in programmed cell death. In one of the cell lines that received the higher dose for the longest time period, a 92 percent reduction in live cells was observed.
The team discovered that grape seed extract increases the availability of a protein called Cip1/p21 which halts the cell cycle and can cause the cells to self-destruct. They also found a decrease in several different cyclin proteins and associated cyclin-dependent kinases (CDKs) which encourage cell division. "This protein physically interacts with CDKs," Dr Agarwal explained. "In normal cells, it attaches to CDKs to inhibit growth, but if a cell wants to grow, as it does in cancer, levels of Cip1/p21 are reduced, or nonfunctional."
When the researchers gave grape seed extract to mice at the same time that one of the human colorectal tumor cell lines was implanted, they found a 44 percent reduction in tumor volume per mouse after eight weeks compared to mice who did not receive the extract. Cip1/p21 protein levels were found to have doubled in the tumors, suggesting a similar mechanism of action as that observed in the cultured cells.
"The value of this preclinical study is that it shows grape seed extract can attack cancer, and how it works, but much more investigation will be needed before these chemicals can be tested as a human cancer treatment and preventive," Dr Agarwal stated.
Interventions that can prevent the development of colorectal cancer include screening for adenomas, removal of polyps by endoscopic polypectomy, excision of the large bowel (in FAP) (Munkholm P 2003; Watson P et al 1998), and regular NSAID use (Reeves MJ et al 1996; Giardiello FM et al 1993), in addition to the following dietary interventions:
Fiber from bran and cellulose is effective in reducing the risk of colorectal cancer development (Gonzalez CA 2006b); Greenwald P et al 1986). In those with low intake of dietary fiber, doubling of total fiber intake could reduce the risk of colorectal cancer by 40 percent (Bingham S 2006). Fruit fiber consumption, as opposed to vegetable fiber, reduces the risk of colorectal adenomas (Platz EA et al 1997). High-fiber foods include legumes, beans, seeds, nuts, wild rice, and oatmeal.
Calcium reduces the growth rate of rectal and colon epithelial cells both directly and by binding bile acids and fatty acids in the stool, resulting in compounds that are less likely to adversely affect the colon (Rozen P et al 1989). Calcium’s beneficial effects may occur only in individuals who have a low level of fat intake (Cats A et al 1995). Oral calcium supplementation reduces benign tumor (adenoma) formation by 19 percent (Baron JA et al 1999) and slightly reduces cell proliferation in the rectum (Cats A et al 1995). Foods such as broccoli, kale, Chinese cabbage, milk, cheese, and yogurt are good sources of calcium.
Curcumin is currently being investigated in human clinical trials for the prevention and treatment of colorectal cancer (Jiao Y et al. 2006a). Curcumin may be effective in preventing the development of colon cancer related to Apc mutations (Corpet DE et al 2003; Pierre F 2003; Reddy BS et al 1994, 2002). The suggested daily dose is 1.6 grams (Perkins S et al 2002). Curcumin is extracted from turmeric root and is used as a spice in cooking.
Multivitamin use reduces the risk of benign tumor (adenoma) formation in high-risk individuals (Whelan RL et al 1999). Vitamins C, E, and A reduce the risk of developing colorectal cancer (Howe GR et al 1992; Newberne PM et al 1990).
Since 1980, Life Extension has been at the forefront in identifying novel and innovative antiaging therapies. Aging first displays its outward signs on the skin. Now, help combat skin aging with our exciting range of skin care products that are years ahead of the commercial cosmetics industry!
We invite you to take advantage of this special Skin Care Sale, and enjoy up to a 60% discount across a range of selected skin care products. Hurry, this incredible sale ends on October 30, 2006.
If you have questions or comments concerning this issue or past issues of Life Extension Update, please send them to email@example.com or call 954 202 7716.
For longer life,
Sign up for Life Extension Update at http://mycart.lef.org/subscribe.asp
Help spread the good news about living longer and healthier. Forward this email to a friend!
View previous issues of Life Extension Update in the Newsletter Archive.